The Latest Cardiac and Vascular News
MONTGOMERY, Ala.–(BUSINESS WIRE)–Kowa Pharmaceuticals America, Inc. announced today that it has entered into an agreement with Allergan plc. to co-promote Allergan’s BYSTOLIC® (nebivolol), a beta blocker approved for the treatment of hypertension to lower blood pressure, in the United States. Kowa’s nationwide sales force will co-promote BYSTOLIC to cardiologists and select […]
REHOVOT, Israel–(BUSINESS WIRE)–Eximo Medical Ltd., announced today the successful launch and first commercial use of the B-Laser™ Atherectomy System for treatment of peripheral vascular disease. Dr. Barry Weinstock of Orlando Heart & Vascular Institute, director of the catheterization laboratory at the Center for Cardiovascular Excellence in Orlando, Florida used the B-Laser™ Atherectomy System to successfully treat a patient […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., announces publication of data for two more tests, HART AS and HART AKI, in its expanding pipeline of multi-protein, AI-driven tests for cardiovascular disease and related conditions. The HART AS data was presented at the 2018 American College of Cardiology Scientific Sessions and was recently published in Open Heart, indicating […]
MALVERN, Pa., Jan. 28, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and Geneva Healthcare, Inc. (“Geneva”), the leading provider of remote monitoring for implantable cardiac […]
REDWOOD CITY, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Pantheris® SV (Small Vessel) image-guided atherectomy system was featured in a live case transmission at Leipzig Interventional Course (LINC) 2019, a leading […]
IRVINE, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today announced its objectives for its upcoming CoreoGraft® study at the Texas Heart Institute. The study will begin the week of January 28. […]
ROCKVILLE, Md., Jan. 28, 2019 /PRNewswire/ — The Heart Failure Society of America (HFSA) has announced that John D. Barnes has been chosen by the Board of Directors as the society’s new Chief Executive Officer. As CEO, he will oversee the implementation of the society’s vision, mission, and strategic plan and assume day-to-day leadership of […]
CARLSBAD, Calif., Jan. 28, 2019 /PRNewswire/ — Acutus Medical today announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac imaging and mapping visualization system in persistent atrial fibrillation (AF) ablation procedures. Results presented at the 24th Annual AF Symposium in Boston show the use of AcQMap resulted in 72.5 percent […]
ALEXANDRIA, Va. and MOUNTAIN VIEW, Calif., Jan. 28, 2019 /PRNewswire/ — Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $20 million senior secured term loan to AliveCor, Inc., a privately held company focused on using artificial intelligence to improve cardiac […]
DUBLIN – January 24, 2019 – Medtronic plc (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire EPIX Therapeutics, Inc. (EPIX), a privately-held medical device company that designs and manufactures a novel, catheter-based, temperature-controlled cardiac ablation system for the treatment of patients with cardiac arrhythmias (irregular […]
